Author details

Full Name

Maura Diamond

Affiliation

ORCID

Career Start Year

2004

Papers

H Index

Expertise

CM4AI Collaborator

PMID	Paper Title	Journal Title	Published Year
29117357	Evaluation of Genetic Predisposition for MYCN-Amplified Neuroblastoma.	J Natl Cancer Inst	2017
28350380	Transcriptomic profiling of 39 commonly-used neuroblastoma cell lines.	Sci Data	2017
28545128	Common variants upstream of MLF1 at 3q25 and within CPZ at 4p16 associated with neuroblastoma.	PLoS Genet	2017
28924153	Common variants in MMP20 at 11q22.2 predispose to 11q deletion and neuroblastoma risk.	Nat Commun	2017
29206221	Corrigendum: Transcriptomic profiling of 39 commonly-used neuroblastoma cell lines.	Sci Data	2017
26100672	CASC15-S Is a Tumor Suppressor lncRNA at the 6p22 Neuroblastoma Susceptibility Locus.	Cancer Res	2015
26560027	Genetic predisposition to neuroblastoma mediated by a LMO1 super-enhancer polymorphism.	Nature	2015
24634504	Rare variants in TP53 and susceptibility to neuroblastoma.	J Natl Cancer Inst	2014
25312269	Common genetic variants in NEFL influence gene expression and neuroblastoma risk.	Cancer Res	2014
23334666	The genetic landscape of high-risk neuroblastoma.	Nat Genet	2013
22941191	Common variation at 6q16 within HACE1 and LIN28B influences susceptibility to neuroblastoma.	Nat Genet	2012
22350409	Common variation at BARD1 results in the expression of an oncogenic isoform that influences neuroblastoma susceptibility and oncogenicity.	Cancer Res	2012
22328350	Replication of neuroblastoma SNP association at the BARD1 locus in African-Americans.	Cancer Epidemiol Biomarkers Prev	2012
21436895	Phenotype restricted genome-wide association study using a gene-centric approach identifies three low-risk neuroblastoma susceptibility Loci.	PLoS Genet	2011
21124317	Integrative genomics identifies LMO1 as a neuroblastoma oncogene.	Nature	2011
19412175	Common variations in BARD1 influence susceptibility to high-risk neuroblastoma.	Nat Genet	2009
19536264	Copy number variation at 1q21.1 associated with neuroblastoma.	Nature	2009
20354569	Cardiac-restricted overexpression of the A(2A)-adenosine receptor in FVB mice transiently increases contractile performance and rescues the heart failure phenotype in mice overexpressing the A(1)-adenosine receptor.	Clin Transl Sci	2008
17728764	Polymorphisms in adenosine receptor genes are associated with infarct size in patients with ischemic cardiomyopathy.	Clin Pharmacol Ther	2007
15081311	Gene expression profiling during the transition to failure in TNF-alpha over-expressing mice demonstrates the development of autoimmune myocarditis.	Journal of Molecular and Cellular Cardiology	2004